These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8843877)

  • 1. Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.
    Seelig HP; Renz M; Targoff IN; Ge Q; Frank MB
    Arthritis Rheum; 1996 Oct; 39(10):1769-71. PubMed ID: 8843877
    [No Abstract]   [Full Text] [Related]  

  • 2. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.
    Seelig HP; Moosbrugger I; Ehrfeld H; Fink T; Renz M; Genth E
    Arthritis Rheum; 1995 Oct; 38(10):1389-99. PubMed ID: 7575689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Mi-2 autoantigen of dermatomyositis.
    Nilasena DS; Trieu EP; Targoff IN
    Arthritis Rheum; 1995 Jan; 38(1):123-8. PubMed ID: 7818561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.
    Ge Q; Nilasena DS; O'Brien CA; Frank MB; Targoff IN
    J Clin Invest; 1995 Oct; 96(4):1730-7. PubMed ID: 7560064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.
    Zhang Y; LeRoy G; Seelig HP; Lane WS; Reinberg D
    Cell; 1998 Oct; 95(2):279-89. PubMed ID: 9790534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anisoosmotic regulation of the Mi-2 autoantigen mRNA in H4IIE rat hepatoma cells and primary hepatocytes.
    Hammermann R; Warskulat U; Häussinger D
    FEBS Lett; 1998 Sep; 435(1):21-4. PubMed ID: 9755851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.
    Wang HB; Zhang Y
    Nucleic Acids Res; 2001 Jun; 29(12):2517-21. PubMed ID: 11410659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain.
    Mierau R; Dick T; Bartz-Bazzanella P; Keller E; Albert ED; Genth E
    Arthritis Rheum; 1996 May; 39(5):868-76. PubMed ID: 8639185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase.
    Wade PA; Jones PL; Vermaak D; Wolffe AP
    Curr Biol; 1998 Jul; 8(14):843-6. PubMed ID: 9663395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies.
    Madaule S; Porte L; Couret B; Arlet-Suau E
    Rheumatology (Oxford); 2000 Oct; 39(10):1157-8. PubMed ID: 11035142
    [No Abstract]   [Full Text] [Related]  

  • 11. Dermatomyositis autoantigen CHD4 forms immune stimulatory complexes with endogenous DNA.
    Guel T; Scholtissek B; Siegl J; Fetter T; Mayer G; Bieber T; Wenzel J
    Exp Dermatol; 2023 Jul; 32(7):965-974. PubMed ID: 36995066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.
    Hengstman GJ; Vree Egberts WT; Seelig HP; Lundberg IE; Moutsopoulos HM; Doria A; Mosca M; Vencovsky J; van Venrooij WJ; van Engelen BG
    Ann Rheum Dis; 2006 Feb; 65(2):242-5. PubMed ID: 16410528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on HLA association of Mi-2 autoantibodies: the association with a tryptophan at position 9 of the HLA-DRbeta chain is strong but not absolute.
    Mierau R; Dick T; Genth E; Bartz-Bazzanella P; Keller E; Albert ED
    Arthritis Rheum; 1999 Jul; 42(7):1552-3. PubMed ID: 10403288
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscles and tendons of a nucleosome remodeling machine.
    Wagner E; Brehm A
    J Mol Biol; 2012 Sep; 422(1):1-2. PubMed ID: 22664199
    [No Abstract]   [Full Text] [Related]  

  • 15. The human Mi-2/NuRD complex and gene regulation.
    Denslow SA; Wade PA
    Oncogene; 2007 Aug; 26(37):5433-8. PubMed ID: 17694084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.
    Mammen AL; Casciola-Rosen LA; Hall JC; Christopher-Stine L; Corse AM; Rosen A
    Arthritis Rheum; 2009 Dec; 60(12):3784-93. PubMed ID: 19950298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dermatomyositis and Autoantibodies].
    Fujimoto M
    Brain Nerve; 2018 Apr; 70(4):427-438. PubMed ID: 29632290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.
    Schmidt DR; Schreiber SL
    Biochemistry; 1999 Nov; 38(44):14711-7. PubMed ID: 10545197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation.
    Wade PA; Gegonne A; Jones PL; Ballestar E; Aubry F; Wolffe AP
    Nat Genet; 1999 Sep; 23(1):62-6. PubMed ID: 10471500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
    Wolstencroft PW; Fiorentino DF
    Curr Rheumatol Rep; 2018 Apr; 20(5):28. PubMed ID: 29637414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.